» Articles » PMID: 15148318

Endoglin Regulates Cytoskeletal Organization Through Binding to ZRP-1, a Member of the Lim Family of Proteins

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 May 19
PMID 15148318
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Endoglin is a component of the transforming growth factor-beta receptor complex abundantly expressed at the surface of endothelial cells and plays an important role in cardiovascular development and vascular remodeling. By using the cytoplasmic domain of endoglin as a bait for screening protein interactors, we have identified ZRP-1 (zyxin-related protein 1), a 476-amino acid member that belongs to a family of LIM containing proteins that includes zyxin and lipoma-preferred partner. The endoglin interacting region was mapped within the three double zinc finger LIM domains of the ZRP-1 C terminus. Analysis of the subcellular distribution of ZRP-1 demonstrated that in the absence of endoglin, ZRP-1 mainly localizes to focal adhesion sites, whereas in the presence of endoglin ZRP-1 is found along actin stress fibers. Because the LIM family of proteins has been shown to associate with the actin cytoskeleton, we investigated the possibility of a regulatory role for endoglin with regard to this structure. Expression of endoglin resulted in a dramatic reorganization of the actin cytoskeleton. In the absence of endoglin, F-actin was localized to dense aggregates of bundles, whereas in the presence of endoglin, expressed in endothelial cells, F-actin was in stress fibers and colocalized with ZRP-1. Furthermore, small interfering RNA-mediated suppression of endoglin or ZRP-1, or clustering of endoglin in endothelial cells, led to mislocalization of F-actin fibers. These results suggest a regulatory role for endoglin, via its interaction with ZRP-1, in the actin cytoskeletal organization.

Citing Articles

Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective.

Gonzalez-Hermosillo L, Cueto-Robledo G, Navarro-Vergara D, Torres-Rojas M, Garcia-Cesar M, Perez-Mendez O Adv Respir Med. 2024; 92(6):485-503.

PMID: 39727495 PMC: 11673787. DOI: 10.3390/arm92060044.


Mining human clinical waste as a rich source of stem cells for neural regeneration.

Eivazi Zadeh Z, Nour S, Kianersi S, Jonidi Shariatzadeh F, Williams R, Nisbet D iScience. 2024; 27(8):110307.

PMID: 39156636 PMC: 11326931. DOI: 10.1016/j.isci.2024.110307.


Editorial: Role of membrane-bound and circulating endoglin in disease.

Bernabeu C, Olivieri C, Rossi E Front Med (Lausanne). 2023; 10:1271756.

PMID: 37731711 PMC: 10507402. DOI: 10.3389/fmed.2023.1271756.


Endoglin in head and neck neoplasms.

Litwiniuk-Kosmala M, Makuszewska M, Czesak M Front Med (Lausanne). 2023; 10:1115212.

PMID: 36844233 PMC: 9950573. DOI: 10.3389/fmed.2023.1115212.


An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms.

Arthur H, Roman B Front Med (Lausanne). 2022; 9:973964.

PMID: 36250069 PMC: 9556665. DOI: 10.3389/fmed.2022.973964.